MX337682B - Metodo para fabricar derivados de almidon de hidroxietilo. - Google Patents
Metodo para fabricar derivados de almidon de hidroxietilo.Info
- Publication number
- MX337682B MX337682B MX2013015075A MX2013015075A MX337682B MX 337682 B MX337682 B MX 337682B MX 2013015075 A MX2013015075 A MX 2013015075A MX 2013015075 A MX2013015075 A MX 2013015075A MX 337682 B MX337682 B MX 337682B
- Authority
- MX
- Mexico
- Prior art keywords
- hydroxyethyl starch
- temperature
- value
- solution
- starch derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/08—Ethers
- C08B31/12—Ethers having alkyl or cycloalkyl radicals substituted by heteroatoms, e.g. hydroxyalkyl or carboxyalkyl starch
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/26—Iron; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
- A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/06—Antianaemics
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/08—Ethers
- C08B31/10—Alkyl or cycloalkyl ethers
-
- C—CHEMISTRY; METALLURGY
- C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
- C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
- C08B31/00—Preparation of derivatives of starch
- C08B31/18—Oxidised starch
- C08B31/185—Derivatives of oxidised starch, e.g. crosslinked oxidised starch
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Polymers & Plastics (AREA)
- Materials Engineering (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Polysaccharides And Polysaccharide Derivatives (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
La invención se refiere a un método para fabricar un almidón de hidroxietilo modificado que lleva un residuo de ácido heptónico en al menos uno de sus extremos. De acuerdo con la invención, las siguientes etapas se llevan a cabo: a) disolver el almidón de hidroxietilo en agua, b) ajustar el valor de pH a un valor de 8.0 a 10.0, c) agregar un compuesto de cianuro a la solución de almidón de hidroxietilo, calentar la solución a una temperatura de 80 a 99°C y mantenerla a esta temperatura durante un primer periodo de tiempo, y d) ajustar el valor de pH a un valor de 2.0 a 4.0, llevar la solución a una temperatura de 50 a 90°C y mantenerla a esta temperatura durante un segundo periodo de tiempo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP11170761A EP2537866A1 (en) | 2011-06-21 | 2011-06-21 | Hydroxyethyl starch derivatives, method for manufacturing the same and therapeutical uses thereof |
| PCT/EP2012/061958 WO2012175608A1 (en) | 2011-06-21 | 2012-06-21 | Method for manufacturing hydroxyethyl starch derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX2013015075A MX2013015075A (es) | 2014-04-14 |
| MX337682B true MX337682B (es) | 2016-03-15 |
Family
ID=44799422
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2013015075A MX337682B (es) | 2011-06-21 | 2012-06-21 | Metodo para fabricar derivados de almidon de hidroxietilo. |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US9181353B2 (es) |
| EP (2) | EP2537866A1 (es) |
| JP (2) | JP6370217B2 (es) |
| CN (2) | CN105348401A (es) |
| BR (1) | BR112013032901A2 (es) |
| CA (1) | CA2837784C (es) |
| CY (1) | CY1121976T1 (es) |
| DK (1) | DK2723774T3 (es) |
| ES (1) | ES2733767T3 (es) |
| HK (1) | HK1220218A1 (es) |
| HR (1) | HRP20191173T1 (es) |
| HU (1) | HUE044428T2 (es) |
| LT (1) | LT2723774T (es) |
| MX (1) | MX337682B (es) |
| PL (1) | PL2723774T3 (es) |
| PT (1) | PT2723774T (es) |
| RS (1) | RS59021B1 (es) |
| SI (1) | SI2723774T1 (es) |
| TR (1) | TR201909574T4 (es) |
| TW (1) | TWI564010B (es) |
| WO (1) | WO2012175608A1 (es) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP6616725B2 (ja) * | 2016-03-31 | 2019-12-04 | 日本製紙株式会社 | 塗工紙用澱粉 |
| SG11202107050RA (en) | 2019-01-10 | 2021-07-29 | Pharmacosmos Holding As | Treating iron deficiency in subjects at risk of cardiovascular adverse events and iron for the management of atrial fibrillation |
| EA202191858A1 (ru) | 2019-06-12 | 2021-11-12 | Фармакосмос Холдинг А/С | Лечение дефицита железа у субъектов с риском нежелательных явлений со стороны сердечно-сосудистой системы и железо для лечения фибрилляции предсердий |
| CN118019542A (zh) | 2021-08-03 | 2024-05-10 | 法码科思莫斯控股有限公司 | 用于在治疗伴侣动物缺铁中皮下使用的铁络合化合物 |
| CN117547549A (zh) * | 2023-11-09 | 2024-02-13 | 黑龙江八一农垦大学 | 适用于犬arf的腹膜透析液与助清除剂的制备方法 |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3639588A (en) * | 1966-10-22 | 1972-02-01 | Fisons Pharmaceuticals Ltd | Pharmaceutical compositions containing ferric hydroxide complexed with dextran or dextrin heptonic acids |
| US4370476A (en) * | 1979-07-17 | 1983-01-25 | Usher Thomas C | Dextran polycarboxylic acids, ferric hydroxide complexes |
| GB8902894D0 (en) * | 1989-02-09 | 1989-03-30 | Fisons Plc | Compositions |
| JPH0566372A (ja) * | 1991-09-10 | 1993-03-19 | Fukui Megane Kogyo Kk | 金属製眼鏡フレーム部品の製造方法 |
| JPH0776524A (ja) * | 1993-07-13 | 1995-03-20 | Takeda Chem Ind Ltd | 動物用抗貧血剤 |
| DK172860B1 (da) | 1998-03-25 | 1999-08-16 | Pharmacosmos Holding As | Jerndextranforbindelse til anvendelse som komponent i et terapeutisk middel til forebyggelse af eller behandling af jernman |
| JP3504506B2 (ja) | 1998-09-17 | 2004-03-08 | 株式会社荏原製作所 | 消音装置 |
| DK173138B1 (da) * | 1998-11-20 | 2000-02-07 | Pharmacosmos Holding As | Fremgangsmåde til fremstilling af en jerndextranforbindelse, jerndextranforbindelse fremstillet efter fremgangsmåden, farma |
| EP1762250A1 (en) * | 2005-09-12 | 2007-03-14 | Fresenius Kabi Deutschland GmbH | Conjugates of hydroxyalkyl starch and an active substance, prepared by chemical ligation via thiazolidine |
| JP5191540B2 (ja) * | 2007-08-17 | 2013-05-08 | アクゾ ノーベル ナムローゼ フェンノートシャップ | グルタミン酸ｎ，ｎ−二酢酸アミド、グルタミン酸ｎ−酢酸アミドｎ−アセトニトリル、これらのアルカリ金属塩、それらの調製プロセス及びそれらの使用 |
| TWI469965B (zh) * | 2008-12-22 | 2015-01-21 | Ono Pharmaceutical Co | 乙炔基吲哚化合物 |
| JP5397991B2 (ja) * | 2009-04-01 | 2014-01-22 | 学校法人東京農業大学 | 乳酸菌を用いたビタミンｂ１２の定量方法 |
-
2011
- 2011-06-21 EP EP11170761A patent/EP2537866A1/en not_active Withdrawn
-
2012
- 2012-06-21 TR TR2019/09574T patent/TR201909574T4/tr unknown
- 2012-06-21 SI SI201231627T patent/SI2723774T1/sl unknown
- 2012-06-21 PT PT12737229T patent/PT2723774T/pt unknown
- 2012-06-21 CA CA2837784A patent/CA2837784C/en active Active
- 2012-06-21 TW TW101122208A patent/TWI564010B/zh active
- 2012-06-21 ES ES12737229T patent/ES2733767T3/es active Active
- 2012-06-21 DK DK12737229.0T patent/DK2723774T3/da active
- 2012-06-21 PL PL12737229T patent/PL2723774T3/pl unknown
- 2012-06-21 US US14/127,766 patent/US9181353B2/en active Active
- 2012-06-21 BR BR112013032901A patent/BR112013032901A2/pt not_active Application Discontinuation
- 2012-06-21 CN CN201510909616.5A patent/CN105348401A/zh active Pending
- 2012-06-21 EP EP12737229.0A patent/EP2723774B1/en active Active
- 2012-06-21 HU HUE12737229 patent/HUE044428T2/hu unknown
- 2012-06-21 LT LTEP12737229.0T patent/LT2723774T/lt unknown
- 2012-06-21 JP JP2014516345A patent/JP6370217B2/ja active Active
- 2012-06-21 CN CN201280029882.3A patent/CN103649128B/zh active Active
- 2012-06-21 WO PCT/EP2012/061958 patent/WO2012175608A1/en active Application Filing
- 2012-06-21 RS RS20190850A patent/RS59021B1/sr unknown
- 2012-06-21 MX MX2013015075A patent/MX337682B/es active IP Right Grant
-
2015
- 2015-10-26 US US14/922,897 patent/US9631032B2/en active Active
-
2016
- 2016-07-12 HK HK16108112.8A patent/HK1220218A1/zh unknown
-
2018
- 2018-03-27 JP JP2018059264A patent/JP2018100424A/ja active Pending
-
2019
- 2019-06-28 HR HRP20191173TT patent/HRP20191173T1/hr unknown
- 2019-07-03 CY CY20191100704T patent/CY1121976T1/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| HUE044428T2 (hu) | 2019-10-28 |
| DK2723774T3 (da) | 2019-07-15 |
| CY1121976T1 (el) | 2020-10-14 |
| EP2723774A1 (en) | 2014-04-30 |
| SI2723774T1 (sl) | 2019-08-30 |
| MX2013015075A (es) | 2014-04-14 |
| CN105348401A (zh) | 2016-02-24 |
| US20140128594A1 (en) | 2014-05-08 |
| HK1220218A1 (zh) | 2017-04-28 |
| BR112013032901A2 (pt) | 2017-01-24 |
| CN103649128A (zh) | 2014-03-19 |
| LT2723774T (lt) | 2019-08-12 |
| TWI564010B (zh) | 2017-01-01 |
| PL2723774T3 (pl) | 2019-10-31 |
| EP2537866A1 (en) | 2012-12-26 |
| JP6370217B2 (ja) | 2018-08-08 |
| JP2018100424A (ja) | 2018-06-28 |
| EP2723774B1 (en) | 2019-04-03 |
| WO2012175608A1 (en) | 2012-12-27 |
| TW201315474A (zh) | 2013-04-16 |
| US20160046733A1 (en) | 2016-02-18 |
| CA2837784C (en) | 2019-10-15 |
| ES2733767T3 (es) | 2019-12-02 |
| US9631032B2 (en) | 2017-04-25 |
| JP2014520188A (ja) | 2014-08-21 |
| RS59021B1 (sr) | 2019-08-30 |
| HRP20191173T1 (hr) | 2019-10-04 |
| TR201909574T4 (tr) | 2019-08-21 |
| CA2837784A1 (en) | 2012-12-27 |
| CN103649128B (zh) | 2016-02-10 |
| US9181353B2 (en) | 2015-11-10 |
| PT2723774T (pt) | 2019-07-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TN2013000411A1 (en) | Branched 3-phenylpropionic acid derivatives and the use thereof | |
| CY1121976T1 (el) | Μεθοδος για την παραγωγη παραγωγων υδροξυαιθυλαμυλου | |
| AR076269A1 (es) | Composicion endulzante que comprende una forma de rebaudiosida a de alta solubilidad y metodo para su produccion | |
| BRPI0922785A2 (pt) | Processos integrados de coprodução de betanol e biodisel, butanol, biocombustíveis e usina integrada de butanol e biodisel. | |
| MX2009008934A (es) | Proceso para la preparacion de algunas sulfiliminas sustituidas. | |
| BR112012015490A2 (pt) | adoçantes e processo para a sua produção | |
| GB2474311B (en) | Low temperature, single solvent process for the production of sucrose-6-ester | |
| HK1160097A1 (en) | Process for the production of ammonia | |
| PL2297079T3 (pl) | Proces wytwarzania kwasu glikolowego | |
| EP2457889A4 (en) | PROCESS FOR THE PREPARATION OF 2-CHLORO-3,3,3-TRIFLUORPROPENES | |
| MX2013003764A (es) | Metodos de elaboracion de fenilacetato de l-ornitina. | |
| EP2463266A4 (en) | PROCESS FOR PRODUCING BIS-QUATERNARY AMMONIUM SALT, AND NOVEL INTERMEDIATE | |
| HK1154589A1 (en) | Crystal of spiroketal derivative, and process for production thereof | |
| UA103597C2 (en) | Trazodone and trazodone hydrochloride in purified form | |
| BR112016023811A2 (pt) | processo de fabricação para derivados de triazina, pirimidina e piridina | |
| MX2019014256A (es) | Metodo para producir compuesto opticamente activo. | |
| BR112017011275A2 (pt) | composição, e, processo para a produção de xarope de glicose. | |
| MX357509B (es) | Sintesis de cleistantina a y derivados de la misma. | |
| UY33511A (es) | Procedimiento de obtención de la forma cristalina ii del febuxostat | |
| IL231677A0 (en) | A crystal of 5-hydroxy-1h-imidazole-4-carboxamide 4/3 hydrate, a method for its production and a crystal of 5-hydroxy-1h-imidazole-4-carboxamide hydrate | |
| EP2770089A4 (en) | METHOD FOR PRODUCING A NITRIDE SEMICONDUCTOR CRYSTAL OF A GROUP 13 METAL OF THE PERIODIC TABLE AND A NITRIDE SEMI-CONDUCTIVE CRYSTAL OF A GROUP 13 METAL OF THE PERIODIC TABLE PRODUCED BY SAID PRODUCTION PROCESS | |
| FR2984322B1 (fr) | Procede de fabrication de composes comprenant des fonctions nitriles | |
| MX2012005733A (es) | Metodo de produccion de derivados de acido glutamico marcados con f-18. | |
| EP2189455A4 (en) | PROCESS FOR PRODUCING HYDRAZINE COMPOUND, INTERMEDIATE FOR PRODUCING HYDRAZINE COMPOUND, AND METHOD FOR MANUFACTURING INTERMEDIATE | |
| IL227396A (en) | METHOD FOR PRODUCING 2,2-DIPLOUROETHYLAMINE FROM 2.2 DIPLOURO-1-CHLOROETHAN AND AMMONIA |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG | Grant or registration |